Utility of gross tumor palpability or tumor size as a measure of drug efficacy for cancer prevention

Authors

Alexander Koh, The University of Texas MD Anderson Cancer Center
Anjana Bhardwaj, The University of Texas MD Anderson Cancer Center
Matthew D. Embury, The University of Texas MD Anderson Cancer Center
Raniv D. Rojo, The University of Texas MD Anderson Cancer Center
Isabelle Bedrosian, The University of Texas MD Anderson Cancer Center

Files

Abstract

View full abstract

DOI

https://doi.org/10.52519/00059

Publication Date

2022

Department

Breast Surgical Oncology

Research Category

The Patient is the Focus

Recommended Citation

Koh, Alexander; Bhardwaj, Anjana; Embury, Matthew D.; Rojo, Raniv D.; and Bedrosian, Isabelle, "Utility of gross tumor palpability or tumor size as a measure of drug efficacy for cancer prevention" (2022). Leading Edge of Cancer Research Symposium. 51.
doi:https://doi.org/10.52519/00059